Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases June 23, 2021
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement June 21, 2021
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares June 21, 2021
Xilio Therapeutics Announces FDA Acceptance of IND Application for XTX101 for the Treatment of Solid Tumors June 17, 2021
Zus Health Closes $34M Series A Led by Andreessen Horowitz (a16z); Participation from F-Prime Capital, Maverick Ventures and Others June 17, 2021
FDA Approves Blueprint Medicines’ AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis June 16, 2021
Beacon Health System Enhances How Patients Find and Schedule Care with Kyruus’ Digital Platform June 15, 2021